Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Vafa Abilova, Amanj Kurdi & Brian Godman. (2018) Ongoing initiatives in Azerbaijan to improve the use of antibiotics; findings and implications. Expert Review of Anti-infective Therapy 16:1, pages 77-84.
Read now
Read now
Brian Godman, Iain Bishop, Alexander E Finlayson, Stephen Campbell, Hye-Young Kwon & Marion Bennie. (2013) Reforms and initiatives in Scotland in recent years to encourage the prescribing of generic drugs, their influence and implications for other countries. Expert Review of Pharmacoeconomics & Outcomes Research 13:4, pages 469-482.
Read now
Read now
Jessica Fraeyman, Guido Van Hal, Brian Godman & Philippe Beutels. (2013) The potential influence of various initiatives to improve rational prescribing for proton pump inhibitors and statins in Belgium. Expert Review of Pharmacoeconomics & Outcomes Research 13:1, pages 141-151.
Read now
Read now
Pieter Dylst, Arnold Vulto & Steven Simoens. (2013) Demand-side policies to encourage the use of generic medicines: an overview. Expert Review of Pharmacoeconomics & Outcomes Research 13:1, pages 59-72.
Read now
Read now
Articles from other publishers (14)
Bregtje W. Kamphuis & Panos Kanavos. (2021) Assessing pricing and reimbursement policies for generic pharmaceuticals in the MENA region for improved efficiency, affordability and generic penetration. Health Policy OPEN 2, pages 100045.
Crossref
Crossref
Mingyue Zhao, Peng Nie & Jing Wu. (2021) Heterogeneity in Price Elasticity of Medicine Demand in China: Moderate Effect From Economic Incentive and Quality Difference. Frontiers in Pharmacology 12.
Crossref
Crossref
Brian Godman, Joseph Fadare, Hye-Young Kwon, Carolina Zampirolli Dias, Amanj Kurdi, Isabella Piassi Dias Godói, Dan Kibuule, Iris Hoxha, Sylvia Opanga, Zikria Saleem, Tomasz Bochenek, Vanda Marković-Peković, Ileana Mardare, Aubrey C Kalungia, Stephen Campbell, Eleonora Allocati, Alice Pisana, Antony P Martin & Johanna C Meyer. (2021) Evidence-based public policy making for medicines across countries: findings and implications for the future. Journal of Comparative Effectiveness Research 10:12, pages 1019-1052.
Crossref
Crossref
Mingyue Zhao, Lingyi Zhang, Zhitong Feng & Yu Fang. (2021) Physicians’ Knowledge, Attitude and Practice of Generic Substitution in China: A Cross-Sectional Online Survey. International Journal of Environmental Research and Public Health 18:15, pages 7749.
Crossref
Crossref
Panos Kanavos, Bregtje W. Kamphuis, Anna-Maria Fontrier, Georgia Colville Parkin, Shadi Saleh & Kasem S. Akhras. (2020) Pricing of in-patent pharmaceuticals in the Middle East and North Africa: Is external reference pricing implemented optimally?. Health Policy 124:12, pages 1297-1309.
Crossref
Crossref
Fatemeh Soleymani, Brian Godman, Pegah Yarimanesh & Abbas Kebriaeezadeh. (2019) Prescribing patterns of physicians working in both the direct and indirect treatment sectors in Iran; findings and implications. Journal of Pharmaceutical Health Services Research 10:4, pages 407-413.
Crossref
Crossref
Brian Godman, Anna Bucsics, Patricia Vella Bonanno, Wija Oortwijn, Celia C. Rothe, Alessandra Ferrario, Simone Bosselli, Andrew Hill, Antony P. Martin, Steven Simoens, Amanj Kurdi, Mohamed Gad, Jolanta Gulbinovič, Angela Timoney, Tomasz Bochenek, Ahmed Salem, Iris Hoxha, Robert Sauermann, Amos Massele, Augusto Alfonso GuerraJr.Jr., Guenka Petrova, Zornitsa Mitkova, Gnosia Achniotou, Ott Laius, Catherine Sermet, Gisbert Selke, Vasileios Kourafalos, John Yfantopoulos, Einar Magnusson, Roberta Joppi, Margaret Oluka, Hye-Young Kwon, Arianit Jakupi, Francis Kalemeera, Joseph O. Fadare, Oyvind Melien, Maciej Pomorski, Magdalene Wladysiuk, Vanda Marković-Peković, Ileana Mardare, Dmitry Meshkov, Tanja Novakovic, Jurij Fürst, Dominik Tomek, Corrine Zara, Eduardo Diogene, Johanna C. Meyer, Rickard Malmström, Björn Wettermark, Zinhle Matsebula, Stephen Campbell & Alan Haycox. (2018) Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets. Frontiers in Public Health 6.
Crossref
Crossref
Nazar AbdulLateef Jassim & Yasameen Abbas Humadi. (2018) The Use of Biosimilars in the Middle East: Review Article. Current Rheumatology Reports 20:7.
Crossref
Crossref
Ranya Hassan, Hafiz Alam Sher, Rabia Khokhar & Rabia Hussain. 2017. Pharmaceutical Policy in Countries with Developing Healthcare Systems. Pharmaceutical Policy in Countries with Developing Healthcare Systems
365
379
.
Richard Ofori-Asenso, Petra Brhlikova & Allyson M. Pollock. (2016) Prescribing indicators at primary health care centers within the WHO African region: a systematic analysis (1995–2015). BMC Public Health 16:1.
Crossref
Crossref
Humayun Riaz, Brian Godman, Shahzad Hussain, Farnaz Malik, Sidra Mahmood, Ali Shami & Sajid Bashir. (2015) Prescribing of bisphosphonates and antibiotics in Pakistan: challenges and opportunities for the future. Journal of Pharmaceutical Health Services Research 6:2, pages 111-121.
Crossref
Crossref
C. Barbui & V. Conti. (2014)
Adherence to generic
v
. brand antidepressant treatment and the key role of health system factors
. Epidemiology and Psychiatric Sciences 24:1, pages 23-26.
Crossref
Crossref
Ranya Shaban Ibrahim Hasan & Charon Lessing. 2015. Pharmaceutical Prices in the 21st Century. Pharmaceutical Prices in the 21st Century
297
307
.
Menno van Woerkom, Hans Piepenbrink, Brian GodmanJoost de Metz, Stephen Campbell, Marion Bennie, Marietta Eimers & Lars L Gustafsson. (2012) Ongoing measures to enhance the efficiency of prescribing of proton pump inhibitors and statins in The Netherlands: influence and future implications. Journal of Comparative Effectiveness Research 1:6, pages 527-538.
Crossref
Crossref